icad inc. Company Profile (NASDAQ:ICAD)

About icad inc. (NASDAQ:ICAD)

icad inc. logoiCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Computer Peripherals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ICAD
  • CUSIP: N/A
  • Web: www.icadmed.com
Capitalization:
  • Market Cap: $64.68 million
  • Outstanding Shares: 16,374,000
Average Prices:
  • 50 Day Moving Avg: $4.10
  • 200 Day Moving Avg: $4.33
  • 52 Week Range: $2.82 - $6.49
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -18.81
  • P/E Growth: -0.52
Sales & Book Value:
  • Annual Revenue: $27.09 million
  • Price / Sales: 2.39
  • Book Value: $1.58 per share
  • Price / Book: 2.50
Profitability:
  • EBIDTA: ($8,280,000.00)
  • Net Margins: -29.61%
  • Return on Equity: -38.00%
  • Return on Assets: -25.34%
Debt:
  • Current Ratio: 1.61%
  • Quick Ratio: 1.32%
Misc:
  • Average Volume: 36,903 shs.
  • Beta: 1.53
  • Short Ratio: 1.09
 
Frequently Asked Questions for icad inc. (NASDAQ:ICAD)

What is icad inc.'s stock symbol?

icad inc. trades on the NASDAQ under the ticker symbol "ICAD."

How were icad inc.'s earnings last quarter?

icad inc. (NASDAQ:ICAD) posted its quarterly earnings data on Thursday, May, 4th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.20) by $0.02. The business earned $6.79 million during the quarter, compared to the consensus estimate of $6.40 million. icad inc. had a negative net margin of 29.61% and a negative return on equity of 38.00%. View icad inc.'s Earnings History.

Where is icad inc.'s stock going? Where will icad inc.'s stock price be in 2017?

1 brokers have issued 12-month target prices for icad inc.'s shares. Their predictions range from $11.00 to $11.00. On average, they expect icad inc.'s share price to reach $11.00 in the next twelve months. View Analyst Ratings for icad inc..

Who are some of icad inc.'s key competitors?

Who are icad inc.'s key executives?

icad inc.'s management team includes the folowing people:

  • Lawrence Howard, Chairman of the Board
  • Kenneth M. Ferry, Chief Executive Officer, Director
  • Richard C. Christopher, Chief Financial Officer, Executive Vice President
  • Stacey M. Stevens, Senior Vice President - Marketing and Strategy
  • Jonathan Go, Senior Vice President - Research and Development
  • R. Scott Areglado, Vice President, Corporate Controller
  • Andrew Heroux Sassine, Director
  • Rachel Brem M.D., Independent Director
  • Anthony F. Ecock, Independent Director
  • Robert L. Goodman M.D., Independent Director

Who owns icad inc. stock?

icad inc.'s stock is owned by many different of institutional and retail investors. Top institutional investors include HARBERT DISCOVERY FUND, LP (6.10%). Company insiders that own icad inc. stock include Kenneth M Ferry and Kevin C Burns. View Institutional Ownership Trends for icad inc..

How do I buy icad inc. stock?

Shares of icad inc. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is icad inc.'s stock price today?

One share of icad inc. stock can currently be purchased for approximately $3.95.


MarketBeat Community Rating for icad inc. (NASDAQ ICAD)
Community Ranking:  2.4 out of 5 ( )
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about icad inc. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for icad inc. (NASDAQ:ICAD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.00 (178.48% upside)

Analysts' Ratings History for icad inc. (NASDAQ:ICAD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/25/2017LaidlawReiterated RatingBuy$11.00MediumView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for icad inc. (NASDAQ:ICAD)
Earnings by Quarter for icad inc. (NASDAQ:ICAD)
Earnings History by Quarter for icad inc. (NASDAQ ICAD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017($0.20)($0.18)$6.40 million$6.79 millionViewListenView Earnings Details
3/8/2017Q4 2016($0.17)($0.20)$6.60 million$6.93 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.14)($0.16)$7.44 million$6.00 millionViewN/AView Earnings Details
7/27/2016Q2($0.14)($0.09)$6.99 million$7.37 millionViewListenView Earnings Details
5/3/2016Q1($0.14)($0.17)$7.27 million$6.04 millionViewN/AView Earnings Details
3/1/2016Q4($0.17)($0.14)$7.77 million$7.61 millionViewN/AView Earnings Details
10/29/2015Q315($0.07)($0.03)$8.09 million$9.58 millionViewListenView Earnings Details
2/24/2015Q414$0.04$0.01$13.30 million$13.20 millionViewN/AView Earnings Details
7/30/2014Q2 2014($0.02)($0.04)$9.02 million$9.67 millionViewN/AView Earnings Details
5/6/2014Q1($0.15)($0.12)$7.95 million$8.50 millionViewListenView Earnings Details
2/19/2014Q4($0.17)($0.41)$8.25 million$9.14 millionViewListenView Earnings Details
10/29/2013Q313($0.20)($0.11)$8.07 million$8.30 millionViewListenView Earnings Details
7/29/2013Q2 2013($0.25)($0.12)$7.56 million$7.71 millionViewListenView Earnings Details
2/19/2013Q4 2012($0.15)$6.61 million$7.82 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for icad inc. (NASDAQ:ICAD)
2017 EPS Consensus Estimate: ($0.61)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.19)($0.19)($0.19)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.14)($0.14)($0.14)
Q4 20171($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for icad inc. (NASDAQ:ICAD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for icad inc. (NASDAQ:ICAD)
Insider Ownership Percentage: 19.10%
Institutional Ownership Percentage: 24.38%
Insider Trades by Quarter for icad inc. (NASDAQ:ICAD)
Insider Trades by Quarter for icad inc. (NASDAQ:ICAD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2016Kenneth M FerryCEOBuy10,000$3.50$35,000.00View SEC Filing  
3/4/2016Kenneth M FerryCEOBuy25,000$4.45$111,250.00View SEC Filing  
3/4/2016Kevin C BurnsCFOBuy10,000$4.44$44,400.00View SEC Filing  
3/19/2015Kenneth M FerryCEOSell100,000$10.00$1,000,000.00View SEC Filing  
3/12/2015Somu SubramaniamDirectorSell50,762$9.23$468,533.26View SEC Filing  
2/10/2015Stacey M StevensSVPSell27,298$10.00$272,980.00View SEC Filing  
12/3/2014Stacey M StevensSVPSell2,502$10.00$25,020.00View SEC Filing  
12/2/2014Stacey M StevensSVPSell503$10.01$5,035.03View SEC Filing  
12/1/2014Stacey M StevensSVPSell299$10.00$2,990.00View SEC Filing  
11/11/2014Kenneth M FerryCEOSell18,318$11.09$203,146.62View SEC Filing  
11/3/2014Stacey M StevensVPSell10,000$11.31$113,100.00View SEC Filing  
10/1/2014Stacey M StevensVPSell13,333$10.00$133,330.00View SEC Filing  
9/3/2014Stacey M StevensVPSell10,000$10.94$109,400.00View SEC Filing  
8/27/2014Kevin C BurnsCFOSell36,439$10.44$380,423.16View SEC Filing  
8/25/2014Kenneth M FerryCEOSell40,000$10.71$428,400.00View SEC Filing  
8/20/2014Stacey M StevensVPSell5,000$10.57$52,850.00View SEC Filing  
8/19/2014Kenneth M FerryCEOSell20,000$10.06$201,200.00View SEC Filing  
8/26/2013Kenneth M FerryCEOBuy5,000$5.55$27,750.00View SEC Filing  
5/3/2013Kevin C BurnsCFOBuy2,900$5.19$15,051.00View SEC Filing  
8/24/2012Kevin C BurnsCFOBuy15,000$2.08$31,200.00View SEC Filing  
8/17/2012Kevin C BurnsCFOBuy28,939$2.90$83,923.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for icad inc. (NASDAQ:ICAD)
Latest Headlines for icad inc. (NASDAQ:ICAD)
Source:
DateHeadline
finance.yahoo.com logoResearchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition
finance.yahoo.com - July 27 at 10:08 PM
finance.yahoo.com logoiCAD announces positive study results comparing use of company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer
finance.yahoo.com - July 25 at 8:02 PM
finance.yahoo.com logoCarolina Breast Imaging Specialists Adopts iCAD’s Advanced Artificial Intelligence Technology for Digital Breast 3D Tomosynthesis
finance.yahoo.com - June 6 at 10:59 AM
finance.yahoo.com logoETFs with exposure to iCAD, Inc. : May 26, 2017
finance.yahoo.com - May 26 at 6:30 PM
finance.yahoo.com logoiCAD, Inc. :ICAD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 25, 2017
finance.yahoo.com - May 25 at 9:03 PM
finance.yahoo.com logoiCAD to Participate in Two Upcoming Investor Conferences
finance.yahoo.com - May 22 at 10:56 AM
finance.yahoo.com logoICAD: Q1: Strong Detection Offsets Weakness in NMSC Revenue
finance.yahoo.com - May 8 at 5:30 PM
finance.yahoo.com logoFirst-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting
finance.yahoo.com - May 5 at 10:51 PM
finance.yahoo.com logoICAD: U.S. Tomo Launched, Should Be 2017 Catalyst
finance.yahoo.com - May 5 at 10:51 PM
nasdaq.com logoPreliminary results show targeted treatment offers low toxicity for patients with endometrial or cervical cancer
www.nasdaq.com - May 5 at 5:49 PM
americanbankingnews.com logoSomewhat Favorable Media Coverage Very Likely to Impact iCAD (ICAD) Share Price
www.americanbankingnews.com - May 4 at 8:50 PM
americanbankingnews.com logoiCAD Inc (ICAD) Posts Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - May 3 at 9:32 PM
cnbc.com logoIcad reports 1Q loss
www.cnbc.com - May 3 at 5:37 PM
finance.yahoo.com logoEdited Transcript of ICAD earnings conference call or presentation 2-May-17 8:30pm GMT
finance.yahoo.com - May 3 at 5:37 PM
finance.yahoo.com logoiCAD Reports First-Quarter 2017 Financial Results
finance.yahoo.com - May 2 at 4:17 PM
finance.yahoo.com logoInvestor Network: iCAD, Inc. to Host Earnings Call
finance.yahoo.com - May 2 at 10:20 AM
finance.yahoo.com logoiCAD Announces First Early-Stage Breast Cancer Patient Treated with Intraoperative Radiation Therapy Using the Xoft System at Monash Cancer Centre, a partnership between Peter MacCallum Cancer Centre and Monash Health in Australia
finance.yahoo.com - May 1 at 1:24 PM
finance.yahoo.com logoiCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American …
finance.yahoo.com - April 26 at 7:31 PM
finance.yahoo.com logoiCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American Society of Breast Surgeons (ASBrS) Annual Meeting
finance.yahoo.com - April 26 at 7:31 PM
feeds.benzinga.com logoiCAD to Report First Quarter 2017 Financial Results on Tuesday, May 2
feeds.benzinga.com - April 24 at 8:28 AM
finance.yahoo.com logoResearchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System …
finance.yahoo.com - April 20 at 11:37 AM
finance.yahoo.com logoResearchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting
finance.yahoo.com - April 20 at 11:37 AM
americanbankingnews.com logoiCAD (ICAD) Earning Very Favorable Media Coverage, Report Finds
www.americanbankingnews.com - April 15 at 8:58 AM
finance.yahoo.com logoICAD: Tomo FDA Approval Sets Stage For Next Growth Phase
finance.yahoo.com - April 11 at 5:35 PM
finance.yahoo.com logoETFs with exposure to iCAD, Inc. : April 5, 2017
finance.yahoo.com - April 7 at 10:22 AM
finance.yahoo.com logoiCAD To Showcase PowerLook Tomo Detection Technology At SBI/ACR Breast Imaging Symposium
finance.yahoo.com - April 7 at 10:22 AM
finance.yahoo.com logoICAD INC Financials
finance.yahoo.com - March 30 at 6:13 PM
investopedia.com logoiCAD Cancer Detecting Product Gets FDA Premarket OK (ICAD)
www.investopedia.com - March 27 at 5:26 PM
investopedia.com logoiCAD Cancer Detecting Product Gets FDA Premarket OK
www.investopedia.com - March 27 at 5:26 PM
finance.yahoo.com logoiCAD Receives FDA Approval For PowerLook Tomo Detection
finance.yahoo.com - March 27 at 11:07 AM
finance.yahoo.com logo8:02 am iCAD announces that PowerLook Tomo Detection has received Premarket Approval from the FDA
finance.yahoo.com - March 27 at 11:07 AM
biz.yahoo.com logoICAD INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 24 at 5:53 PM
finance.yahoo.com logoICAD: NMSC Utilization Revenue Ramp Taking Longer
finance.yahoo.com - March 14 at 11:56 AM
seekingalpha.com logoiCAD's (ICAD) CEO Ken Ferry on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 9 at 8:55 PM
biz.yahoo.com logoICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 9 at 8:55 PM
finance.yahoo.com logoiCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System
finance.yahoo.com - March 9 at 3:53 PM
americanbankingnews.com logoiCAD Inc (ICAD) Posts Earnings Results
www.americanbankingnews.com - March 9 at 12:21 PM
biz.yahoo.com logoQ4 2016 ICAD Inc Earnings Release - After Market Close
us.rd.yahoo.com - March 8 at 11:36 PM
cnbc.com logoIcad reports 4Q loss
www.cnbc.com - March 8 at 6:36 PM
finance.yahoo.com logoiCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017
finance.yahoo.com - March 3 at 5:49 PM
finance.yahoo.com logoiCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017
finance.yahoo.com - March 3 at 5:49 PM
finance.yahoo.com logoiCAD to Present at the 29th Annual ROTH Conference
finance.yahoo.com - March 2 at 6:12 PM
finance.yahoo.com logoiCAD to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call on Wednesday, March 8, 2017
finance.yahoo.com - February 27 at 6:47 PM
biz.yahoo.com logoICAD INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets
biz.yahoo.com - February 8 at 6:33 PM
finance.yahoo.com logoICAD: Certain Catalysts Expected to Return ICAD to Positive Revenue Growth in 2017
finance.yahoo.com - February 8 at 6:33 PM
biz.yahoo.com logoICAD INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
us.rd.yahoo.com - December 22 at 11:07 PM
us.rd.yahoo.com logo2:12 pm iCAD discloses that Invivo Corp purchased all right, title, & interest to certain intellectual property relating to the VersaVue Software, the DynaCAD product, & related assets for about $3.2 mln
us.rd.yahoo.com - December 22 at 11:07 PM
reuters.com logoBRIEF-Icad says entered into asset purchase agreement with Invivo Corp- SEC filing
www.reuters.com - December 22 at 6:06 PM
biz.yahoo.com logoICAD INC Files SEC form 8-K, Other Events
biz.yahoo.com - December 16 at 6:23 PM
finance.yahoo.com logoFirst-Ever Analysis of Intraoperative Radiation Therapy with Xoft System as a Boost Prior to Whole Breast …
finance.yahoo.com - December 6 at 10:26 AM

Social

Chart

icad inc. (ICAD) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff